J 2017

Intravenous thrombolysis for patients with in-hospital stroke onset: propensity-matched analysis from the Safe Implementation of Treatments in Stroke-East registry

TSIVGOULIS, G., A.H. KATSANOS, P. KADLECOVA, A. CZLONKOWSKA, A. KOBAYASHI et. al.

Basic information

Original name

Intravenous thrombolysis for patients with in-hospital stroke onset: propensity-matched analysis from the Safe Implementation of Treatments in Stroke-East registry

Authors

TSIVGOULIS, G. (300 Greece), A.H. KATSANOS (300 Greece), P. KADLECOVA (203 Czech Republic), A. CZLONKOWSKA (616 Poland), A. KOBAYASHI (616 Poland), M. BROZMAN (703 Slovakia), V. SVIGELJ (705 Slovenia), L. CSIBA (348 Hungary), K. FEKETE (348 Hungary), J. KORV (233 Estonia), V. DEMARIN (191 Croatia), A. VILIONSKIS (440 Lithuania), D. JATUZIS (440 Lithuania), Y. KRESPI (792 Turkey), T. KARAPANAYIOTIDES (300 Greece), S. GIANNOPOULOS (300 Greece) and Robert MIKULÍK (203 Czech Republic, guarantor, belonging to the institution)

Edition

European Journal of Neurology, Oxford, Rapid Science Ltd. 2017, 1351-5101

Other information

Language

English

Type of outcome

Článek v odborném periodiku

Field of Study

30210 Clinical neurology

Country of publisher

United States of America

Confidentiality degree

není předmětem státního či obchodního tajemství

Impact factor

Impact factor: 4.621

RIV identification code

RIV/00216224:14110/17:00099191

Organization unit

Faculty of Medicine

UT WoS

000415723800016

Keywords in English

acute ischaemic stroke; door-to-needle time; in-hospital stroke; intravenous thrombolysis; onset-to-treatment time; stroke awareness

Tags

Tags

International impact, Reviewed
Změněno: 21/3/2018 18:15, Soňa Böhmová

Abstract

V originále

Background and purposeRecent cross-sectional study data suggest that intravenous thrombolysis (IVT) in patients with in-hospital stroke (IHS) onset is associated with unfavorable functional outcomes at hospital discharge and in-hospital mortality compared to patients with out-of-hospital stroke (OHS) onset treated with IVT. We sought to compare outcomes between IVT-treated patients with IHS and OHS by analysing propensity-score-matched data from the Safe Implementation of Treatments in Stroke-East registry. MethodsWe compared the following outcomes for all propensity-score-matched patients: (i) symptomatic intracranial hemorrhage defined with the safe implementation of thrombolysis in stroke-monitoring study criteria, (ii) favorable functional outcome defined as a modified Rankin Scale (mRS) score of 0-1 at 3 months, (iii) functional independence defined as an mRS score of 0-2 at 3 months and (iv) 3-month mortality. ResultsOut of a total of 19 077 IVT-treated patients with acute ischaemic stroke, 196 patients with IHS were matched to 5124 patients with OHS, with no differences in all baseline characteristics (P > 0.1). Patients with IHS had longer door-to-needle [90 (interquartile range, IQR, 60-140) vs. 65 (IQR, 47-95) min, P < 0.001] and door-to-imaging [40 (IQR, 20-90) vs. 24 (IQR, 15-35) min, P < 0.001] times compared with patients with OHS. No differences were detected in the rates of symptomatic intracranial hemorrhage (1.6% vs. 1.9%, P = 0.756), favorable functional outcome (46.4% vs. 42.3%, P = 0.257), functional independence (60.7% vs. 60.0%, P = 0.447) and mortality (14.3% vs. 15.1%, P = 0.764). The distribution of 3-month mRS scores was similar in the two groups (P = 0.273). ConclusionsOur findings underline the safety and efficacy of IVT for IHS. They also underscore the potential of reducing in-hospital delays for timely tissue plasminogen activator delivery in patients with IHS.